Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS)
Pennisi, Marzio, Russo, Giulia, Sgroi, Giuseppe, Bonaccorso, Angela, Parasiliti Palumbo, Giuseppe Alessandro, Fichera, Epifanio, Mitra, Dipendra Kumar, Walker, Kenneth B, Cardona, Pere-Joan, Amat, Merce, Viceconti, Marco, Pappalardo, Francesco
Published in BMC bioinformatics (10.12.2019)
Published in BMC bioinformatics (10.12.2019)
Get full text
Journal Article
RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice
Prabowo, Satria A, Painter, Hannah, Zelmer, Andrea, Smith, Steven G, Seifert, Karin, Amat, Merce, Cardona, Pere-Joan, Fletcher, Helen A
Published in Frontiers in immunology (30.04.2019)
Published in Frontiers in immunology (30.04.2019)
Get full text
Journal Article
Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection
Nell, Andre S, D'lom, Eva, Bouic, Patrick, Sabaté, Montserrat, Bosser, Ramon, Picas, Jordi, Amat, Mercè, Churchyard, Gavin, Cardona, Pere-Joan
Published in PloS one (26.02.2014)
Published in PloS one (26.02.2014)
Get full text
Journal Article
Synthesis and Biological Evaluation of 2-Phenylpyran-4-ones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors
Caturla, Francisco, Jiménez, Juan-Miguel, Godessart, Núria, Amat, Mercè, Cárdenas, Alvaro, Soca, Lídia, Beleta, Jordi, Ryder, Hamish, Crespo, María I
Published in Journal of medicinal chemistry (15.07.2004)
Published in Journal of medicinal chemistry (15.07.2004)
Get full text
Journal Article
LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS
CARDONA IGLESIAS PERE JOAN, AMAT RIERA ISABEL, REYES BLANCA, SELGA ARIADNA, AMAT MERCE
Year of Publication 20.02.2014
Get full text
Year of Publication 20.02.2014
Patent
Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection: e89612
Nell, Andre S, D'lom, Eva, Bouic, Patrick, Sabate, Montserrat, Bosser, Ramon, Picas, Jordi, Amat, Merce, Churchyard, Gavin, Cardona, Pere-Joan
Published in PloS one (01.02.2014)
Published in PloS one (01.02.2014)
Get full text
Journal Article
Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx super([registered]) and Arcoxia super([registered])
Caturla, Francisco, Amat, Merce, Reinoso, Raquel F, Cordoba, Monica, Warrellow, Graham
Published in Bioorganic & medicinal chemistry letters (01.06.2006)
Published in Bioorganic & medicinal chemistry letters (01.06.2006)
Get full text
Journal Article
LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS
SELGA, ARIADNA, CARDONA IGLESIAS, PERE J, AMAT, MERCE, REYES, BLANCA, AMAT RIERA, ISABEL
Year of Publication 23.07.2019
Get full text
Year of Publication 23.07.2019
Patent
Efficacy of RUTI® immunotherapy against active tuberculosis in a mouse model challenges the Koch phenomenon
Soldevilla, Pablo, Buisan, Anna, Diaz, Jorge, Saladrigas, Sergi, Rosales, Yaiza, Arias, Lilibeth, Jimenez-Melsio, Alexandra, Vilaplana, Cristina, Amat Fabregat, Merce, Cardona, Pere-Joan
Published in Frontiers in Tuberculosis (08.11.2023)
Published in Frontiers in Tuberculosis (08.11.2023)
Get full text
Journal Article
Formulación de lipomosas adecuada para tratar o prevenir la tuberculosis
REYES BLANCA, SELGA ARIADNA, CARDONA PERE JOAN, AMAT ISABEL, AMAT MERCE
Year of Publication 29.11.2013
Get full text
Year of Publication 29.11.2013
Patent
LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS
AMAT, ISABEL, SELGA, ARIADNA, AMAT, MERCE, REYES, BLANCA, CARDONA, PERE JOAN
Year of Publication 27.12.2012
Get full text
Year of Publication 27.12.2012
Patent
LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS
AMAT, ISABEL, SELGA, ARIADNA, AMAT, MERCE, REYES, BLANCA, CARDONA, PERE JOAN
Year of Publication 12.07.2012
Get full text
Year of Publication 12.07.2012
Patent
LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS
AMAT, ISABEL, SELGA, ARIADNA, AMAT, MERCE, REYES, BLANCA, CARDONA, PERE JOAN
Year of Publication 12.07.2012
Get full text
Year of Publication 12.07.2012
Patent
Liposome formulation suitable for treating or preventing tuberculosis
AMAT, ISABEL, SELGA, ARIADNA, AMAT, MERCE, REYES, BLANCA, CARDONA, PERE JOAN
Year of Publication 04.07.2012
Get full text
Year of Publication 04.07.2012
Patent
Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: mortality prognostic study
Amat, M, Barcons, M, Mancebo, J, Mateo, J, Oliver, A, Mayoral, J F, Fontcuberta, J, Vila, L
Published in Critical care medicine (01.01.2000)
Published in Critical care medicine (01.01.2000)
Get more information
Journal Article
Liposome formulation suitable for treating or preventing tuberculosis
REYES BLANCA, SELGA ARIADNA, CARDONA PERE JOAN, AMAT ISABEL, AMAT MERCE
Year of Publication 27.10.2017
Get full text
Year of Publication 27.10.2017
Patent
Racemic and Chiral Sulfoxides as Potential Prodrugs of the COX-2 Inhibitors Vioxx® and Arcoxia
Caturla, Francisco, Amat, Merce, Reinoso, Raquel F., Cordoba, Monica, Warrellow, Graham
Published in ChemInform (19.09.2006)
Published in ChemInform (19.09.2006)
Get full text
Journal Article